Salim Syed
Stock Analyst at Mizuho Securities
(0.86)
# 3,766
Out of 4,429 analysts
1099
Total ratings
42.9%
Success rate
-1%
Average return
Main Sectors:
Stocks Rated by Salim Syed
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTX Nkarta | Maintained: Buy | $12 | $2.79 | +330.11% | 42 | Jun 22, 2026 | |
| AMGN Amgen | Maintained: Hold | $303 | $344.72 | -12.10% | 171 | Jun 21, 2026 | |
| BBIO BridgeBio Pharma | Maintained: Buy | $96 | $68.92 | +39.29% | 107 | Jun 21, 2026 | |
| ATRA Atara Biotherapeutics | Maintained: Buy | $18 | $10.54 | +70.78% | 81 | Jun 18, 2026 | |
| PCVX Vaxcyte | Maintained: Buy | $163 | $52.11 | +212.80% | 24 | Jun 18, 2026 | |
| BIIB Biogen | Rated: Buy | $236 → $221 | $199.71 | +10.66% | 132 | Jun 12, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | $170 | $124.87 | +36.14% | 111 | Jun 12, 2026 | |
| ASMB Assembly Biosciences | Maintained: Buy | $40 → $45 | $25.06 | +79.57% | 40 | Jun 12, 2026 | |
| WVE Wave Life Sciences | Maintained: Buy | $27 | $6.17 | +337.60% | 80 | Jun 12, 2026 | |
| AUTL Autolus Therapeutics | Maintained: Buy | $10 | $1.49 | +571.14% | 6 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $2.30 | +247.83% | 3 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $62 | $45.96 | +34.90% | 17 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $43 | $19.32 | +122.57% | 8 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $97 | $25.57 | +279.35% | 3 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 → $25 | $10.36 | +141.31% | 8 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $84 → $100 | $79.17 | +26.31% | 145 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $90 → $121 | $103.66 | +16.73% | 6 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $2.15 | +272.09% | 2 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $27.23 | +65.26% | 4 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $85 | $54.36 | n/a | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $4.06 | n/a | 3 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $115.48 | n/a | 2 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $14.01 | n/a | 2 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 | $25.08 | n/a | 1 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $2.99 | n/a | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.49 | n/a | 73 | Jun 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $9.70 | n/a | 1 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $55.90 | n/a | 1 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $23.02 | n/a | 1 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7.1 | $15.60 | n/a | 1 | Jul 2, 2019 |
Nkarta
Jun 22, 2026
Maintained: Buy
Price Target: $12
Current: $2.79
Upside: +330.11%
Amgen
Jun 21, 2026
Maintained: Hold
Price Target: $303
Current: $344.72
Upside: -12.10%
BridgeBio Pharma
Jun 21, 2026
Maintained: Buy
Price Target: $96
Current: $68.92
Upside: +39.29%
Atara Biotherapeutics
Jun 18, 2026
Maintained: Buy
Price Target: $18
Current: $10.54
Upside: +70.78%
Vaxcyte
Jun 18, 2026
Maintained: Buy
Price Target: $163
Current: $52.11
Upside: +212.80%
Biogen
Jun 12, 2026
Rated: Buy
Price Target: $236 → $221
Current: $199.71
Upside: +10.66%
Gilead Sciences
Jun 12, 2026
Maintained: Buy
Price Target: $170
Current: $124.87
Upside: +36.14%
Assembly Biosciences
Jun 12, 2026
Maintained: Buy
Price Target: $40 → $45
Current: $25.06
Upside: +79.57%
Wave Life Sciences
Jun 12, 2026
Maintained: Buy
Price Target: $27
Current: $6.17
Upside: +337.60%
Autolus Therapeutics
Jun 10, 2026
Maintained: Buy
Price Target: $10
Current: $1.49
Upside: +571.14%
Jun 10, 2026
Maintained: Buy
Price Target: $8
Current: $2.30
Upside: +247.83%
Jun 2, 2026
Maintained: Buy
Price Target: $45 → $62
Current: $45.96
Upside: +34.90%
Mar 30, 2026
Maintained: Buy
Price Target: $45 → $43
Current: $19.32
Upside: +122.57%
Mar 30, 2026
Maintained: Buy
Price Target: $97
Current: $25.57
Upside: +279.35%
Mar 24, 2026
Rated: Buy
Price Target: $30 → $25
Current: $10.36
Upside: +141.31%
Mar 18, 2026
Rated: Buy
Price Target: $84 → $100
Current: $79.17
Upside: +26.31%
Dec 8, 2025
Upgraded: Buy
Price Target: $90 → $121
Current: $103.66
Upside: +16.73%
Nov 14, 2025
Maintained: Buy
Price Target: $8
Current: $2.15
Upside: +272.09%
Aug 18, 2025
Maintained: Buy
Price Target: $45
Current: $27.23
Upside: +65.26%
May 20, 2025
Maintained: Buy
Price Target: $85
Current: $54.36
Upside: n/a
May 9, 2025
Maintained: Buy
Price Target: $10
Current: $4.06
Upside: n/a
Nov 22, 2024
Rated: Hold
Price Target: n/a
Current: $115.48
Upside: n/a
Nov 22, 2024
Rated: Hold
Price Target: n/a
Current: $14.01
Upside: n/a
May 28, 2024
Maintained: Buy
Price Target: $53
Current: $25.08
Upside: n/a
Mar 25, 2024
Maintained: Buy
Price Target: $25
Current: $2.99
Upside: n/a
Jun 16, 2023
Rated: Hold
Price Target: n/a
Current: $1.49
Upside: n/a
Mar 6, 2023
Maintained: Buy
Price Target: $21
Current: $9.70
Upside: n/a
Nov 3, 2022
Maintained: Buy
Price Target: $23
Current: $55.90
Upside: n/a
Aug 4, 2022
Maintained: Buy
Price Target: $25
Current: $23.02
Upside: n/a
Jul 2, 2019
Maintained: Buy
Price Target: $7.1
Current: $15.60
Upside: n/a